Angiodynamics Inc (ANGO)
9.00 -0.31 (-3.33%) 04/08/25 [NASDAQ]
8.71 x 8,000 14.31 x 100
Realtime by (Cboe BZX)
8.71 x 8,000 14.31 x 100
Realtime - - (-) -
for Tue, Apr 8th, 2025
Fiscal Year End Date: 05/31
(Values in U.S. thousands)
05-2024 | 05-2023 | 05-2022 | 05-2021 | 05-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -184,349 | -52,442 | -26,547 | -31,548 | -166,787 |
Depreciation Amortization | 187,188 | 45,422 | 29,349 | 25,916 | 182,383 |
Income taxes - deferred | -7,968 | -2,311 | -3,708 | -4,805 | -1,568 |
Accounts receivable | 7,894 | -1,299 | -17,151 | -4,162 | 11,918 |
Other Working Capital | 14,421 | -7,026 | -21,047 | 9,072 | -28,549 |
Other Operating Activity | -45,344 | 17,734 | 31,910 | 29,620 | -11,951 |
Operating Cash Flow | $-28,158 | $78 | $-7,194 | $24,093 | $-14,554 |
Cash Flows From Investing Activities | |||||
PPE Investments | 131,982 | -3,812 | -4,297 | -5,187 | -7,235 |
Net Acquisitions | N/A | N/A | -3,600 | N/A | -55,760 |
Purchase Sale Intangibles | -3,250 | -540 | 0 | N/A | -350 |
Other Investing Activity | -8,265 | -5,934 | -11,410 | -8,524 | -350 |
Investing Cash Flow | $123,717 | $-9,746 | $-19,307 | $-13,711 | $-63,345 |
Cash Flows From Financing Activities | |||||
Debt Issued | 0 | 70,000 | 5,000 | N/A | 40,000 |
Debt Repayment | -50,000 | -45,000 | 0 | -20,000 | -132,500 |
Common Stock Issued | 752 | 1,171 | 2,683 | N/A | -759 |
Other Financing Activity | -15,000 | -751 | 0 | 3,014 | -1,983 |
Financing Cash Flow | $-64,248 | $25,420 | $7,683 | $-16,986 | $-95,242 |
Exchange Rate Effect | 125 | 43 | -518 | 330 | -65 |
Beginning Cash Position | 44,620 | 28,825 | 48,161 | 54,435 | 227,641 |
End Cash Position | 76,056 | 44,620 | 28,825 | 48,161 | 54,435 |
Net Cash Flow | $31,436 | $15,795 | $-19,336 | $-6,274 | $-173,206 |
Free Cash Flow | |||||
Operating Cash Flow | -28,158 | 78 | -7,194 | 24,093 | -14,554 |
Capital Expenditure | -2,518 | -3,812 | -4,297 | -5,187 | -7,235 |
Free Cash Flow | -30,676 | -3,734 | -11,491 | 18,906 | -21,789 |